Marinus Pharmaceuticals, Inc. - stock earnings
MRNS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -41.8 million USD | 7.2 million USD |
| 2023Q3 | -33.0 million USD | 7.3 million USD |
| 2023Q2 | -31.9 million USD | 6.1 million USD |
| 2023Q1 | -34.6 million USD | 10.4 million USD |
| 2022Q4 | -34.3 million USD | 7.2 million USD |
| 2022Q3 | 71.6 million USD | 2.3 million USD |
| 2022Q2 | -42.1 million USD | 1.8 million USD |
| 2022Q1 | -21.1 million USD | 14.2 million USD |
| 2021Q4 | -28.3 million USD | 1.5 million USD |
| 2021Q3 | -19.5 million USD | 10.1 million USD |
| 2021Q2 | -23.8 million USD | 1.9 million USD |
| 2021Q1 | -27.1 million USD | 1.8 million USD |
| 2020Q4 | -17.5 million USD | 1.5 million USD |
| 2020Q3 | -15.7 million USD | 171000 USD |
| 2020Q2 | -15.7 million USD | ? USD |
| 2020Q1 | -18.7 million USD | ? USD |
| 2019Q4 | -15.4 million USD | ? USD |
| 2019Q3 | -13.8 million USD | ? USD |
| 2019Q2 | -12.4 million USD | ? USD |
| 2019Q1 | -12.5 million USD | ? USD |
| 2018Q4 | -10.1 million USD | ? USD |
| 2018Q3 | -11.1 million USD | ? USD |
| 2018Q2 | -9.5 million USD | ? USD |
| 2018Q1 | -6.0 million USD | ? USD |
| 2017Q4 | -4.7 million USD | ? USD |
| 2017Q3 | -4.2 million USD | ? USD |
| 2017Q2 | -4.6 million USD | ? USD |
| 2017Q1 | -5.4 million USD | ? USD |
| 2016Q4 | -6.0 million USD | ? USD |
| 2016Q3 | -6.5 million USD | ? USD |
| 2016Q2 | -8.9 million USD | ? USD |
| 2016Q1 | -7.2 million USD | ? USD |
| 2015Q4 | -7.6 million USD | ? USD |
| 2015Q3 | -5.0 million USD | ? USD |
| 2015Q2 | -5.3 million USD | ? USD |
| 2015Q1 | -7.0 million USD | ? USD |
| 2014Q4 | -3.6 million USD | ? USD |
| 2014Q3 | -1.7 million USD | ? USD |
| 2014Q2 | -3.3 million USD | ? USD |
| 2014Q1 | -2.2 million USD | ? USD |
| 2013Q4 | -1.4 million USD | ? USD |
| 2013Q3 | -1.2 million USD | ? USD |
| 2013Q2 | -1.7 million USD | ? USD |
| 2013Q1 | -969643 USD | ? USD |
| 2012Q4 | ? USD | 100000 USD |
MRNS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -141.4 million USD | 31.0 million USD |
| 2022 | -19.8 million USD | 25.5 million USD |
| 2021 | -101.7 million USD | 15.3 million USD |
| 2020 | -66.6 million USD | 1.7 million USD |
| 2019 | -53.8 million USD | ? USD |
| 2018 | -36.7 million USD | ? USD |
| 2017 | -18.9 million USD | ? USD |
| 2016 | -28.6 million USD | ? USD |
| 2015 | -24.9 million USD | ? USD |
| 2014 | -10.8 million USD | ? USD |
| 2013 | -5.3 million USD | ? USD |
| 2012 | -1.4 million USD | 100000 USD |
MRNS
Price: $1.51
52 week price:
Earnings Per Share: -2.63 USD
P/E Ratio: -3.59
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 214200
Ebitda: -19.9 millionMarket Capitalization: 475.4 million